Preoperative GLP-1 Receptor Agonist Use and Weight Loss Outcomes Following Bariatric Surgery
Preoperative GLP-1 use was not associated with postoperative weight loss in a statewide, multi-system cohort, including in an active-comparator analysis among patients with type 2 diabetes. These findings suggest preoperative GLP-1 therapy is unlikely to compromise MBS weight loss outcomes.
Authors
- Tarik K. Yuce (ORCID: https://orcid.org/0000-0002-4575-6368)
- Emma Holler (ORCID: https://orcid.org/0000-0002-4424-925X)
- Jason M. Samuels (ORCID: https://orcid.org/0000-0001-5427-3117)
- Dimitrios Stefanidis
Institutions
- Indiana University – Purdue University Indianapolis (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1097/sla.0000000000007042
- Primary Topic
- Bariatric Surgery and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00